ARTICLE
10 October 2016

FDA Requests Comments On The Judicious Use Of Medically Important Antimicrobial Drugs In Food-Producing Animals

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
FDA requested comments regarding the establishment of appropriately targeted durations of use of antimicrobial drugs of importance to human medicine when they are administered in the feed or water of food-producing animals.
United States Food, Drugs, Healthcare, Life Sciences

In the September 13, 2016, Federal Register, FDA requested comments regarding the establishment of appropriately targeted durations of use of antimicrobial drugs of importance to human medicine (i.e., medically important antimicrobial drugs) when they are administered in the feed or water of food-producing animals for therapeutic purposes. In March 2015, FDA developed "The National Action Plan for Combating Antibiotic-Resistant Bacteria," a plan presenting a strategy for collaborative action by the U.S. government in coordination with individuals and organizations within the human and animal health sectors with the goal of implementing interventions that can reduce the spread of antimicrobial resistance. The plan was developed in response to President Obama's 2014 Executive Order 13676 on "Combating Antibiotic-Resistant Bacteria." Comments are due December 13, 2016.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More